(Q46990171)

English

In-vitro and in-vivo characterization of a buprenorphine delivery system

scientific article published in March 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16536895

In-vitro and in-vivo characterization of a buprenorphine delivery system (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16536895

author name string

Sofie R Kleppner

1

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16536895

Raj Patel

2

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16536895

Joseph McDonough

3

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16536895

Lauren C Costantini

4

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16536895

publication date

1 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16536895

Journal of Pharmacy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16536895

58

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16536895

3

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16536895

295-302

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16536895

Implantable technology for long-term delivery of nalmefene for treatment of alcoholism

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.3.0002

21 January 2018

Release kinetics of 3-keto-desogestrel from contraceptive implants (Implanon) in dogs: comparison with in vitro data

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.3.0002

21 January 2018

A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.3.0002

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.3.0002

21 January 2018

Opioid effects and opioid withdrawal during a 24 h dosing interval in patients maintained on buprenorphine

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.3.0002

21 January 2018

Identifiers

10.1211/JPP.58.3.0002

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16536895

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 December 2017

http://europepmc.org/abstract/MED/16536895

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46990171&oldid=2141000987"